COVIDIEN FORTREX 0.035 OTW PTA BALLOON CATHETER; CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINA
|
Back to Search Results |
|
Catalog Number A35HPV06080080 |
Device Problems
Deformation Due to Compressive Stress (2889); Detachment of Device or Device Component (2907)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/27/2021 |
Event Type
malfunction
|
Event Description
|
Physician was attempting to use fortrex pta balloon catheter during procedure to treat a plaque lesion in the left mid radial bone cephalic vein.The vessel was severely tortuous.The vessel diameter and lesion length are 6m and 8mm respectively.No embolic protection was used.A syringe was used for balloon inflation.There was no issue noted when removing device from hoop/tray.The device was prepped per ifu with no issue identified.The vessel was stenosed.The catheter/delivery system was deformed with a kink on the shaft noted.The device did not pass through a previously deployed stent.There was no resistance encountered when advancing the device.It is reported that the event occurred during the shunt percutaneous transluminal angioplasty (pta).After passing the wire through, when the device was passed through the lesion, the shaft of the balloon portion broke in several places and the device could not be advanced.The balloon was replaced with another product and inflation was performed to complete the procedure.There was no patient injury reported.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Additional information: catheter break issue occurred while the device was in the patient.No detachment occurred from device.No injury to the patient as a result of issue.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Product analysis: the fortrex device was returned to medtronic investigation lab for evaluation.The device was returned coiled inside two biohazard bags.A 20ml water filled syringe was used to flush the device.A guidewire was loaded through the tip and met resistance approximately 11mm from the distal marker band.A microscopic inspection revealed a kink in the inner lumen approximately 11mm from the distal marker band.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|